In addition, mutations in the CHEK2, ATM and BRIP1 genes confer a moderate lifetime risk of breast cancer but are rare and account for less than 5 % of familial breast cancer cases [1, 2]. This evidence concerns the gene CHEK2 and breast carcinoma.